Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type

Abstract

Chemokine receptor polymorphisms have a modifying effect on the virological response to HAART. Multivariate analysis demonstrated that heterozygosity for the CCR5-Delta32-bp variant is an independent prognostic factor for treatment outcome.